BTX161
BTX161 is a thalidomide analog that mediates degradation of CKIα better than lenalidomide in human AML cells and activates DDR and p53.
Product Specifications
CAS Number
2052301-24-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
272.304
Molecular Formula
C15H16N2O3
Notes
Research use only, not for human use.
Receptor
Casein Kinase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog